|
|
Suppliers for
Abiraterone acetate
|
Properties | CAS |
154229-18-2 | Formula |
C26H33NO2 |
|
|
16 Registered suppliers
Molecular Formula: C26H33NO2 Molecular Weight: 391.55
More details are to be found here
Specification | CP/USP
| Documentation | DMF under Filing |
Specification | CP/USP
| Documentation | DMF under Filing |
Specification | CP/USP
| Documentation | DMF under Filing |
Specification | CP/USP
| Documentation | DMF under Filing |
Specification | CP/USP
| Documentation | DMF under Filing |
Description : The acetate form of abiraterone, which blocks the synthesis of androgens by inhibiting CYP17A1. It can be used to treat metastatic, castration-resistant prostate cancer. - Molecular Weight :391.55
- Melting Point :127-130 °C
- Purity :> 98%
Molecular Formula : C26H33NO2 Canonical SMILES : CC(=O)OC1CCC2(C3CCC4(C(C3CC=C2C1)CC=C4C5=CN=CC=C5)C)C InChI : InChI=1S/C26H33NO2/c1-17(28)29-20-10-12-25(2)19(15-20)6-7-21-23-9-8-22(18-5-4-14-27-16-18)26(23,3)13-11-24(21)25/h4-6,8,14,16,20-21,23-24H,7,9-13,15H2,1-3H3/t20-,21-,23-,24-,25-,26+/m0/s1 InChIKey : UVIQSJCZCSLXRZ-UBUQANBQSA-N Appearance : Off-white solid Application : the treatment of metastatic, castration-resistant prostate cancer Synonyms : CB7630; Zytiga; CB-7630; CB7630; Abiraterone (acetate)
More details are to be found here
Description : The acetate form of abiraterone, which blocks the synthesis of androgens by inhibiting CYP17A1. It can be used to treat metastatic, castration-resistant prostate cancer. - Molecular Weight :391.55
- Melting Point :127-130 °C
- Purity :> 98%
Molecular Formula : C26H33NO2 Canonical SMILES : CC(=O)OC1CCC2(C3CCC4(C(C3CC=C2C1)CC=C4C5=CN=CC=C5)C)C InChI : InChI=1S/C26H33NO2/c1-17(28)29-20-10-12-25(2)19(15-20)6-7-21-23-9-8-22(18-5-4-14-27-16-18)26(23,3)13-11-24(21)25/h4-6,8,14,16,20-21,23-24H,7,9-13,15H2,1-3H3/t20-,21-,23-,24-,25-,26+/m0/s1 InChIKey : UVIQSJCZCSLXRZ-UBUQANBQSA-N Appearance : Off-white solid Application : the treatment of metastatic, castration-resistant prostate cancer Synonyms : CB7630; Zytiga; CB-7630; CB7630; Abiraterone (acetate)
More details are to be found here
Description : The acetate form of abiraterone, which blocks the synthesis of androgens by inhibiting CYP17A1. It can be used to treat metastatic, castration-resistant prostate cancer. - Molecular Weight :391.55
- Melting Point :127-130 °C
- Purity :> 98%
Molecular Formula : C26H33NO2 Canonical SMILES : CC(=O)OC1CCC2(C3CCC4(C(C3CC=C2C1)CC=C4C5=CN=CC=C5)C)C InChI : InChI=1S/C26H33NO2/c1-17(28)29-20-10-12-25(2)19(15-20)6-7-21-23-9-8-22(18-5-4-14-27-16-18)26(23,3)13-11-24(21)25/h4-6,8,14,16,20-21,23-24H,7,9-13,15H2,1-3H3/t20-,21-,23-,24-,25-,26+/m0/s1 InChIKey : UVIQSJCZCSLXRZ-UBUQANBQSA-N Appearance : Off-white solid Application : the treatment of metastatic, castration-resistant prostate cancer Synonyms : CB7630; Zytiga; CB-7630; CB7630; Abiraterone (acetate)
More details are to be found here
Description : The acetate form of abiraterone, which blocks the synthesis of androgens by inhibiting CYP17A1. It can be used to treat metastatic, castration-resistant prostate cancer. - Molecular Weight :391.55
- Melting Point :127-130 °C
- Purity :> 98%
Molecular Formula : C26H33NO2 Canonical SMILES : CC(=O)OC1CCC2(C3CCC4(C(C3CC=C2C1)CC=C4C5=CN=CC=C5)C)C InChI : InChI=1S/C26H33NO2/c1-17(28)29-20-10-12-25(2)19(15-20)6-7-21-23-9-8-22(18-5-4-14-27-16-18)26(23,3)13-11-24(21)25/h4-6,8,14,16,20-21,23-24H,7,9-13,15H2,1-3H3/t20-,21-,23-,24-,25-,26+/m0/s1 InChIKey : UVIQSJCZCSLXRZ-UBUQANBQSA-N Appearance : Off-white solid Application : the treatment of metastatic, castration-resistant prostate cancer Synonyms : CB7630; Zytiga; CB-7630; CB7630; Abiraterone (acetate)
More details are to be found here
Description : The acetate form of abiraterone, which blocks the synthesis of androgens by inhibiting CYP17A1. It can be used to treat metastatic, castration-resistant prostate cancer. - Molecular Weight :391.55
- Melting Point :127-130 °C
- Purity :> 98%
Molecular Formula : C26H33NO2 Canonical SMILES : CC(=O)OC1CCC2(C3CCC4(C(C3CC=C2C1)CC=C4C5=CN=CC=C5)C)C InChI : InChI=1S/C26H33NO2/c1-17(28)29-20-10-12-25(2)19(15-20)6-7-21-23-9-8-22(18-5-4-14-27-16-18)26(23,3)13-11-24(21)25/h4-6,8,14,16,20-21,23-24H,7,9-13,15H2,1-3H3/t20-,21-,23-,24-,25-,26+/m0/s1 InChIKey : UVIQSJCZCSLXRZ-UBUQANBQSA-N Appearance : Off-white solid Application : the treatment of metastatic, castration-resistant prostate cancer Synonyms : CB7630; Zytiga; CB-7630; CB7630; Abiraterone (acetate)
More details are to be found here
Description : The acetate form of abiraterone, which blocks the synthesis of androgens by inhibiting CYP17A1. It can be used to treat metastatic, castration-resistant prostate cancer. - Molecular Weight :391.55
- Melting Point :127-130 °C
- Purity :> 98%
Molecular Formula : C26H33NO2 Canonical SMILES : CC(=O)OC1CCC2(C3CCC4(C(C3CC=C2C1)CC=C4C5=CN=CC=C5)C)C InChI : InChI=1S/C26H33NO2/c1-17(28)29-20-10-12-25(2)19(15-20)6-7-21-23-9-8-22(18-5-4-14-27-16-18)26(23,3)13-11-24(21)25/h4-6,8,14,16,20-21,23-24H,7,9-13,15H2,1-3H3/t20-,21-,23-,24-,25-,26+/m0/s1 InChIKey : UVIQSJCZCSLXRZ-UBUQANBQSA-N Appearance : Off-white solid Application : the treatment of metastatic, castration-resistant prostate cancer Synonyms : CB7630; Zytiga; CB-7630; CB7630; Abiraterone (acetate)
More details are to be found here
|
|
|
Privileged suppliers
Last update 2024-04-26
|